Biomerieux S A Unsp/Adr (BMXXY) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello and welcome to the BioMero H1 2025 Financial Performance Call. Please note this webcast is being recorded and for the first part, participants' lines will be in listen-only mode. You will have the opportunity to ask questions at the end of the presentation. This can be done by pressing pound key 5 on your telephone keypad. I will now hand the conference over to Americ Fichet, Head of Investor Relations. Hello, everyone. Good afternoon and thank you for joining this call. Please note that this conference call will include forwarding statements that may change or be modified due to uncertainties and risks related to the company's environment. Accordingly, we cannot give any assurance as to whether we will achieve this objective. I also remind you that today's call is being recorded and that a replay will be available I will now hand the call over to Thierry, and then we will open the call to discussion and questions. Thierry? Hello everyone, good morning, good afternoon. So I'm going to share with you, first of all, key highlights for this first half of the year, and then I'll follow up with business highlights, then I will hand over to Dionne, who will share an extensive update on the financial performance and then I will hand over to me to discuss about guidance that will be issued for the full year 2025 and will open for joining. So, key highlights, if we look at the key numbers for the first half of 2025, a very strong 9.4% sell growth, which we see as a very solid performance in the market. mostly driven by double-digit growth in all of the Go28 growth drivers, together with strong performance for respiratory panels. What we believe remarkable in the first half of the year is that together with this 9.4% sales growth, we've managed to achieve close to 24% li...